| 2016-10-05 08:04:29|
TLGT 08:04 10/05 10/05/16
Teligent unit receives approval from Health Canada for Lidocaine Ointment USP 5%
Teligent announced that its Estonian subsidiary, Teligent Oundefined, has received approval from Health Canada's Therapeutic Products Directorate for Lidocaine Ointment USP 5%. This is the sixth approval for Teligent Oundefined this calendar year and will be distributed by Teligent's business in Canada. Based on internal estimates, the total addressable market for this product is approximately C$1.3M.